Search

Your search keyword '"Saunders, Mark"' showing total 11 results

Search Constraints

Start Over You searched for: Author "Saunders, Mark" Remove constraint Author: "Saunders, Mark" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years Publisher springer nature Remove constraint Publisher: springer nature
11 results on '"Saunders, Mark"'

Search Results

1. Observation of triple J/ψ meson production in proton-proton collisions

2. RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.

3. PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer.

4. Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990-2014).

5. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.

7. SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.

8. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.

9. Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer.

10. Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.

11. Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer.

Catalog

Books, media, physical & digital resources